EUVIMEDEUVIMED entdecken
Open Access

Copy number gain of FAM131B-AS2 promotes the progression of glioblastoma by mitigating replication stress

Shaobo Wang, Yanhua Qi, Rongrong Zhao, Ziwen Pan, Boyan Li, Wei Qiu, Shulin Zhao, Xiaofan Guo, Shilei Ni, Gang Li iD, Hao Xue

Neuro-Oncology · 2024

DOI: 10.1093/neuonc/noae014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, 2024. Verfasst von Shaobo Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Qilu Hospital, Cheeloo College of Medicine, Institute of Brain and Brain-Inspired Science, Shandong University, Jinan, Sh…. Hauptthemen laut MEDLINE: Glioblastoma, RNA, Long Noncoding, Brain Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province of China, Jinan Science and Technology Bureau of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glioblastoma (GBM) is characterized by chromosome 7 copy number gains, notably 7q34, potentially contributing to therapeutic resistance, yet the underlying oncogenes have not been fully characterized. Pertinently, the significance of long noncoding RNAs (lncRNAs) in this context has gained attention, necessitating further exploration.

Methods

FAM131B-AS2 was quantified in GBM samples and cells using qPCR. Overexpression and knockdown of FAM131B-AS2 in GBM cells were used to study its functions in vivo and in vitro. The mechanisms of FAM131B-AS2 were studied using RNA-seq, qPCR, Western blotting, RNA pull-down, coimmunoprecipitation assays, and mass spectrometry analysis. The phenotypic changes that resulted from FAM131B-AS2 variation were evaluated through CCK8 assay, EdU assay, comet assay, and immunofluorescence.

Results

Our analysis of 149 primary GBM patients identified FAM131B-AS2, a lncRNA located in the 7q34 region, whose upregulation predicts poor survival. Mechanistically, FAM131B-AS2 is a crucial regulator of the replication stress response, stabilizing replication protein A1 through recruitment of ubiquitin-specific peptidase 7 and activating the ataxia telangiectasia and rad3-related protein kinase pathway to protect single-stranded DNA from breakage. Furthermore, FAM131B-AS2 overexpression inhibited CD8+ T-cell infiltration, while FAM131B-AS2 inhibition activated the cGAS-STING pathway, increasing lymphocyte infiltration and improving the response to immune checkpoint inhibitors.

Conclusions

FAM131B-AS2 emerges as a promising indicator for adjuvant therapy response and could also be a viable candidate for combined immunotherapies against GBMs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaRNA, Long NoncodingBrain NeoplasmsHumansMiceAnimalsGene Expression Regulation, NeoplasticCell ProliferationDNA Copy Number VariationsUbiquitin-Specific Peptidase 7PrognosisDisease ProgressionBiomarkers, TumorTumor Cells, CulturedDNA ReplicationXenograft Model Antitumor AssaysApoptosisAtaxia Telangiectasia Mutated ProteinsSurvival RateMice, NudeCell Line, TumorMaleFemale

Stichwörter der Autor:innen

copy number gainglioblastomaimmune checkpoint inhibitorslncRNAreplication stress

Substanzen

RNA, Long NoncodingUbiquitin-Specific Peptidase 7USP7 protein, humanBiomarkers, TumorAtaxia Telangiectasia Mutated ProteinsATM protein, human

Autor:innen und Institutionen

  • Department of Neurosurgery, Qilu Hospital, Cheeloo College of Medicine, Institute of Brain and Brain-Inspired Science, Shandong University, Jinan, Shandong, China.
  • Shandong Key Laboratory of Brain Function Remodeling, Jinan, Shandong, China.
  • Department of Neurology, Loma Linda University Health, Loma Linda, California, USA.

ORCID-Profile: Gang Li

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province of China
  • Jinan Science and Technology Bureau of Shandong Province
  • Key Research and Development Program of Shandong Province
  • Key Clinical Research Project of Clinical Research Center of Shandong University
  • China Postdoctoral Science Foundation
  • Postdoctoral Innovation Foundation of Shandong Province of China
  • Taishan Pandeng Scholar Program of Shandong Province

Zitieren

APA

Wang, S., Qi, Y., Zhao, R., Pan, Z., Li, B., Qiu, W., Zhao, S., Guo, X., Ni, S., Li, G., & Xue, H. (2024). Copy number gain of FAM131B-AS2 promotes the progression of glioblastoma by mitigating replication stress. Neuro-Oncology. https://doi.org/10.1093/neuonc/noae014

Vancouver

Wang S, Qi Y, Zhao R, Pan Z, Li B, Qiu W, et al. Copy number gain of FAM131B-AS2 promotes the progression of glioblastoma by mitigating replication stress. Neuro-Oncology. 2024. doi:10.1093/neuonc/noae014

BibTeX
@article{Wang2024,
  author = {Wang, Shaobo and Qi, Yanhua and Zhao, Rongrong and Pan, Ziwen and Li, Boyan and Qiu, Wei and Zhao, Shulin and Guo, Xiaofan and Ni, Shilei and Li, Gang and Xue, Hao},
  title = {Copy number gain of FAM131B-AS2 promotes the progression of glioblastoma by mitigating replication stress},
  journal = {Neuro-Oncology},
  year = {2024},
  doi = {10.1093/neuonc/noae014}
}
Kostenlos starten →